This site is intended for health professionals only

Published on 22 June 2007

Share this story:

RELATED ARTICLES
Ability to stand on one leg for 10s associated with reduced mortality risk
Cannabis use not linked to increased respiratory-related hospital visits
Methotrexate suspension for 2 weeks after COVID-19 vaccination boosts antibody response
Hospital discharge smoking cessation programs found to be equivalent
Review questions benefit of adding intranasal antihistamines to inhaled steroids in allergic rhinitis

US go-ahead for Exforge

teaser

Novartis has received US approval for Exforge



Most read

1
Feedback: Automation systems in your hospital
2
Merck agrees huge Vioxx settlement
3
Helapet introduce new, improved 20mm Vented Vial Adapter
4
Janssen-Cilag’s Stelara approved by NICE
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Xarelto single pill backed by NICE in final guidance
Pharmacoeconomics of Alzheimer’s disease
FDA extends leukaemia drug use
Notice of the annual general meeting
Afatinib approved in Europe for patients with EGFR mutation positive lung cancer